• Pandemic Inspires Impactful Public-Private Partnerships

    Clinical Research News | If COVID-19 has an upside, it’s that the public health crisis has turned fierce competitors unto friendly collaborators and forged unlikely partnerships between groups who tackle problems from a different angle.

    Jul 28, 2020

  • How St. Jude Research Hospital’s New SVP of Clinical Trials Administration is Weathering the Pandemic

    Clinical Research News | While the short-term impacts of the COVID-19 pandemic have certainly slowed clinical research, St. Jude’s new Senior Vice President of Clinical Trials Administration keeps a long view, with some initial goals—including an expanded clinical infrastructure and informatics—becoming more important than ever.

    Jul 27, 2020

  • NIAID Establishes COVID-19 Prevention Network, Other News

    Clinical Research News | The NIAID recently established the COVID-19 Prevention Network with the goal to register millions of volunteers for large-scale clinical testing of vaccines and monoclonal antibodies intended to protect people from COVID-19. This, plus more, is included in this week’s announcements and updates from the clinical research industry.

    Jul 24, 2020

  • Accelerating Toward a New Era of Clinical Research

    Clinical Research News Contributed Commentary | The modern clinical trial will reduce the patient burden, increase speed of execution, and improve collaboration across stakeholders.

    Jul 23, 2020

  • Anthony Fauci: Pandemic Potential of Coronaviruses Nothing New

    Clinical Research News | In his opening keynote address at the American Association for Cancer Research virtual meeting on COVID-19 and cancer yesterday, Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases, stayed true to his reputation as a beacon of knowledge and truth in the battle against a confounding viral foe.

    Jul 21, 2020

  • 2000 Volunteers Urge NIH to Begin Human Challenge Trials For COVID-19

    Clinical Research NewsMore than 100 researchers, clinicians, and Nobel Laureates signed a letter sent to Francis Collins, director of the National Institutes of Health, yesterday emphasizing the “vast importance of human challenge trials” in developing a vaccine for COVID-19.

    Jul 17, 2020